Regional Sales Director, Midwest
5070 N. 40th Street
Phoenix, AZ 85018
Full package of health and other benefits available.
Based in the Chicago area (or other suitable Midwest location), the Regional Sales Director (RSD) is responsible for leading CND’s sales plan for a multi-state geography covering 2,000-3,000 neurologists and other physicians. The goal of the RSD is to drive sustained adoption of CND’s Syn-One Test and other products the company develops to help clinicians diagnose neurological disorders. The RSD role is part of a new direct sales function for the company and will include hiring and managing a team of 4-5 regional sales executives (RSEs) and independent sales agents. Additionally, the RSD may be asked to collaborate with strategic partners engaged to help drive awareness of the company’s products to stimulate leads and ultimate sales. Over time, it is expected this role will report to a Vice President of Sales, but until that time reports directly to the CEO and works closely with other CND leaders, founders and the rest of the commercial team. The RSD, in a player-coach model, has individual sales goals as well as those covering the total region.
Specific responsibilities include:
- Develop individual territory plan to target and onboard new clinical customers for CND, with specific focus on top neurology practices covering movement disorders, cognitive impairment, autonomic dysfunction, sleep disorders and general neurology.
- Ensure strong competency in promoting CND’s products by completing ongoing training and refining selling skills both for in-person and digital engagement.
- Advance personal knowledge of customer base including clinical practice patterns and trends, diagnostic needs, skin biopsy capabilities, and other relevant characteristics.
- Build a base of KOLs and conduct in-service training and educational programs that support awareness and appropriate adoption of CND products.
- Leverage CND’s marketing programs, Medical Affairs resources, and other capabilities to drive sales.
- Utilize CND’s CRM and other software tools to drive sales productivity and efficiencies.
- Serve as the region manager and team lead to accomplish overall regional sales goal, with an overall objective of achieving $10 million in diagnostic sales within the first five years.
- Collaborate with CND management to develop an overall region plan with defined strategies to achieve goals; present plans and progress regularly to CND management and colleagues, covering standard KPIs.
- Confirm an overall talent plan for the region and geographic coverage with both direct sales staff and possible independent sales agents.
- Help develop and deploy ongoing training programs for the sales team.
- Define job descriptions for RSEs and recruit, hire and onboard 4-5 RSEs in the first three years.
- Serve as an effective and consistent coach to the RSEs, bolstering their knowledge and capabilities and providing appropriate guidance and motivation.
- Ensure consistent culture, philosophy, and ethics practiced by the team as well as compliance to all CND rules and SOPs.
- Work closely and regularly with the Senior Manager, Client Services and Client Account Managers (CAMs) assigned to clinician customers once they begin utilizing CND’s products.
- Develop and follow customer pre-sales and onboarding procedures with the assigned CAMs and ensure smooth and efficient interactions with new accounts to maximize satisfaction.
- Align on the ongoing account management procedures including how account ownership, communication, and support services are provided seamlessly.
How to Apply
Please send cover email and CV to [email protected].
About Our Organization
Founded in 2017, CND Life Sciences is dedicated to supporting the care of patients suffering from neurodegenerative diseases and other related conditions. Operating a CLIA-certified laboratory in Phoenix, Arizona, CND launched the Syn-One Test as the world's first commercially available test to detect and visualize the presence of abnormal, misfolded alpha-synuclein located in cutaneous nerve fibers. The test, which analyzes small skin biopsies collected conveniently from the patient in a physician’s office, serves as an accurate diagnostic confirmation of a synucleinopathy. The Syn-One Test leverages a decade of published science from leading academic institutions in multiple countries and has demonstrated high levels of sensitivity and specificity. The company has research collaborations with multiple biopharmaceutical companies and in 2020 was awarded a prestigious NIH SBIR award to advance the validation and clinical utility of its Syn-One Test. For more information visit www.cndlifesciences.com.
Disclosure: Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R44NS117214. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.